Insights

Key Personnel Expansion Expansion Therapeutics has recently onboarded key scientific and business leaders to its team, such as Melissa A. Starovasnik, Kenneth S. Kosik, and Leonard Petrucelli. Leveraging the expertise and network of these individuals could open doors for collaboration opportunities and market expansion.

Strategic Financials With a total funding of $135M and revenues ranging from $0 - 10M, Expansion Therapeutics stands in a strong financial position to drive growth and invest in innovative solutions. This financial stability can be leveraged to explore new partnerships and scale business operations effectively.

SAB Additions Driving Innovation The recent appointments of scientific experts like Raymond J. Kelleher and Sudhir Rao to Expansion Therapeutics' board highlight the company's commitment to fostering innovation. Engaging with these leaders could lead to insights on cutting-edge research and development trends, presenting sales opportunities in emerging therapeutic areas.

Strategic Investment Influx Expansion Therapeutics secured a significant investment of $80M from leading entities like Citadel and Cormorant Asset Management. This influx of funds indicates investor confidence in the company's vision and potential. Utilizing these resources effectively can fuel business expansion and create avenues for strategic partnerships.

RNA Therapeutics Focus As a pioneer in developing oral medicines for RNA-mediated diseases, Expansion Therapeutics is at the forefront of RNA-targeted drug discovery. The company's unique platform and focus on expansion repeat diseases present a niche market opportunity for tailored therapeutic solutions. Leveraging this expertise could lead to collaborations with organizations seeking innovative RNA-based treatments.

Expansion Therapeutics Tech Stack

Expansion Therapeutics uses 8 technology products and services including MySQL, Font Awesome, jQuery, and more. Explore Expansion Therapeutics's tech stack below.

  • MySQL
    Database
  • Font Awesome
    Font Scripts
  • jQuery
    Javascript Libraries
  • Lodash
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Python
    Programming Languages
  • reCAPTCHA
    Security
  • Nginx
    Web Servers

Media & News

Expansion Therapeutics's Email Address Formats

Expansion Therapeutics uses at least 1 format(s):
Expansion Therapeutics Email FormatsExamplePercentage
FLast@expansionrx.comJDoe@expansionrx.com
49%
FirstLa@expansionrx.comJohnDo@expansionrx.com
1%
FLast@expansionrx.comJDoe@expansionrx.com
49%
FirstLa@expansionrx.comJohnDo@expansionrx.com
1%

Frequently Asked Questions

Where is Expansion Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Expansion Therapeutics's main headquarters is located at 555 Heritage Dr Suite 150 Jupiter, Florida 33458 US. The company has employees across 2 continents, including North AmericaEurope.

What is Expansion Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Expansion Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Expansion Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Expansion Therapeutics's official website is expansionrx.com and has social profiles on LinkedIn.

How much revenue does Expansion Therapeutics generate?

Minus sign iconPlus sign icon
As of November 2024, Expansion Therapeutics's annual revenue reached $3.8M.

What is Expansion Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Expansion Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Expansion Therapeutics have currently?

Minus sign iconPlus sign icon
As of November 2024, Expansion Therapeutics has approximately 34 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: R. S.Founder: M. D.Svp, Biology: E. M.. Explore Expansion Therapeutics's employee directory with LeadIQ.

What industry does Expansion Therapeutics belong to?

Minus sign iconPlus sign icon
Expansion Therapeutics operates in the Biotechnology Research industry.

What technology does Expansion Therapeutics use?

Minus sign iconPlus sign icon
Expansion Therapeutics's tech stack includes MySQLFont AwesomejQueryLodashModernizrPythonreCAPTCHANginx.

What is Expansion Therapeutics's email format?

Minus sign iconPlus sign icon
Expansion Therapeutics's email format typically follows the pattern of . Find more Expansion Therapeutics email formats with LeadIQ.

How much funding has Expansion Therapeutics raised to date?

Minus sign iconPlus sign icon
As of November 2024, Expansion Therapeutics has raised $135M in funding. The last funding round occurred on Sep 29, 2021 for $80M.

When was Expansion Therapeutics founded?

Minus sign iconPlus sign icon
Expansion Therapeutics was founded in 2016.
Expansion Therapeutics

Expansion Therapeutics

Biotechnology ResearchFlorida, United States11-50 Employees

Expansion Therapeutics is a drug discovery and development company pursuing the vast potential of small molecule medicines for RNA-mediated diseases. Expansion has assembled the intellectual property, know-how, and proprietary enabling technologies and tools necessary to facilitate the creation of potent and specific small molecule binders of RNA. Through this unique platform, Expansion is building a portfolio of novel RNA-targeted drug candidates with activity across a broad number of disease indications. The company’s initial development focus is on therapies for patients with expansion repeat diseases who currently have limited and unsatisfactory treatment options. Expansion is based in Jupiter, Florida

Section iconCompany Overview

Headquarters
555 Heritage Dr Suite 150 Jupiter, Florida 33458 US
Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $135M

    Expansion Therapeutics has raised a total of $135M of funding over 2 rounds. Their latest funding round was raised on Sep 29, 2021 in the amount of $80Mas a Series B.

  • $10M

    Expansion Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $135M

    Expansion Therapeutics has raised a total of $135M of funding over 2 rounds. Their latest funding round was raised on Sep 29, 2021 in the amount of $80Mas a Series B.

  • $10M

    Expansion Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.